These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 39066219)

  • 21. A multi-omic brain gut microbiome signature differs between IBS subjects with different bowel habits.
    Sarnoff RP; Bhatt RR; Osadchiy V; Dong T; Labus JS; Kilpatrick LA; Chen Z; Subramanyam V; Zhang Y; Ellingson BM; Naliboff B; Chang L; Mayer EA; Gupta A
    Neuropharmacology; 2023 Mar; 225():109381. PubMed ID: 36539012
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fecal bacteria and short-chain fatty acids in irritable bowel syndrome: Relations to subtype.
    Teige ES; Hillestad EMR; Steinsvik EK; Brønstad I; Lundervold A; Lundervold AJ; Valeur J; Hausken T; Berentsen B; Lied GA
    Neurogastroenterol Motil; 2024 Sep; 36(9):e14854. PubMed ID: 38946176
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence for an association of gut microbial Clostridia with brain functional connectivity and gastrointestinal sensorimotor function in patients with irritable bowel syndrome, based on tripartite network analysis.
    Labus JS; Osadchiy V; Hsiao EY; Tap J; Derrien M; Gupta A; Tillisch K; Le Nevé B; Grinsvall C; Ljungberg M; Öhman L; Törnblom H; Simren M; Mayer EA
    Microbiome; 2019 Mar; 7(1):45. PubMed ID: 30898151
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Altered profiles of fecal metabolites correlate with visceral hypersensitivity and may contribute to symptom severity of diarrhea-predominant irritable bowel syndrome.
    Zhang WX; Zhang Y; Qin G; Li KM; Wei W; Li SY; Yao SK
    World J Gastroenterol; 2019 Nov; 25(43):6416-6429. PubMed ID: 31798278
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased Ileal Immunoglobulin A Production and Immunoglobulin A-Coated Bacteria in Diarrhea-Predominant Irritable Bowel Syndrome.
    Liu Y; Yuan X; Li L; Lin L; Zuo X; Cong Y; Li Y
    Clin Transl Gastroenterol; 2020 Mar; 11(3):e00146. PubMed ID: 32352710
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multi-Omics Analysis of Gut Microbiota and Host Transcriptomics Reveal Dysregulated Immune Response and Metabolism in Young Adults with Irritable Bowel Syndrome.
    Chen J; Zhao T; Li H; Xu W; Maas K; Singh V; Chen MH; Dorsey SG; Starkweather AR; Cong XS
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542485
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fecal and Mucosa-Associated Intestinal Microbiota in Patients with Diarrhea-Predominant Irritable Bowel Syndrome.
    Maharshak N; Ringel Y; Katibian D; Lundqvist A; Sartor RB; Carroll IM; Ringel-Kulka T
    Dig Dis Sci; 2018 Jul; 63(7):1890-1899. PubMed ID: 29777439
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multi-omics Analysis of Gut Microbiota and Metabolites in Rats With Irritable Bowel Syndrome.
    Liu S; Si C; Yu Y; Zhao G; Chen L; Zhao Y; Zhang Z; Li H; Chen Y; Min L; Zhang S; Zhu S
    Front Cell Infect Microbiol; 2019; 9():178. PubMed ID: 31192167
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gut microbiome and symptoms in females with irritable bowel syndrome: a cross-sectional analysis.
    Kamp KJ; Plantinga AM; Cain KC; Burr RL; Tsai CS; Wu Q; So SY; Badu S; Savidge T; Shulman RJ; Heitkemper MM
    Benef Microbes; 2024 May; 15(3):259-273. PubMed ID: 38821492
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiomics Study of Gut Bacteria and Host Metabolism in Irritable Bowel Syndrome and Depression Patients.
    Xu C; Jia Q; Zhang L; Wang Z; Zhu S; Wang X; Liu Y; Li M; Zhang J; Wang X; Zhang J; Sun Q; Wang K; Zhu H; Duan L
    Front Cell Infect Microbiol; 2020; 10():580980. PubMed ID: 33194817
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fecal bacteria can predict the efficacy of rifaximin in patients with diarrhea-predominant irritable bowel syndrome.
    Li Y; Hong G; Yang M; Li G; Jin Y; Xiong H; Qian W; Hou X
    Pharmacol Res; 2020 Sep; 159():104936. PubMed ID: 32470562
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The function of the gut microbiota-bile acid-TGR5 axis in diarrhea-predominant irritable bowel syndrome.
    Zhan K; Wu H; Xu Y; Rao K; Zheng H; Qin S; Yang Y; Jia R; Chen W; Huang S
    mSystems; 2024 Mar; 9(3):e0129923. PubMed ID: 38329942
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors.
    Lin H; Guo Q; Wen Z; Tan S; Chen J; Lin L; Chen P; He J; Wen J; Chen Y
    Microb Cell Fact; 2021 Dec; 20(1):233. PubMed ID: 34963452
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gut Bacterial Dysbiosis in Irritable Bowel Syndrome: a Case-Control Study and a Cross-Cohort Analysis Using Publicly Available Data Sets.
    Kim GH; Lee K; Shim JO
    Microbiol Spectr; 2023 Feb; 11(1):e0212522. PubMed ID: 36652592
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microbial community and metabolomic comparison of irritable bowel syndrome faeces.
    Ponnusamy K; Choi JN; Kim J; Lee SY; Lee CH
    J Med Microbiol; 2011 Jun; 60(Pt 6):817-827. PubMed ID: 21330412
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Significant Differences in Gut Microbiota Between Irritable Bowel Syndrome with Diarrhea and Healthy Controls in Southwest China.
    Yao C; Li Y; Luo L; Xie F; Xiong Q; Li T; Yang C; Feng PM
    Dig Dis Sci; 2023 Jan; 68(1):106-127. PubMed ID: 35503487
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differences in Fecal Microbiomes and Metabolomes of People With vs Without Irritable Bowel Syndrome and Bile Acid Malabsorption.
    Jeffery IB; Das A; O'Herlihy E; Coughlan S; Cisek K; Moore M; Bradley F; Carty T; Pradhan M; Dwibedi C; Shanahan F; O'Toole PW
    Gastroenterology; 2020 Mar; 158(4):1016-1028.e8. PubMed ID: 31843589
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sex-based differences in fecal short-chain fatty acid and gut microbiota in irritable bowel syndrome patients.
    Sun QH; Liu ZJ; Zhang L; Wei H; Song LJ; Zhu SW; He MB; Duan LP
    J Dig Dis; 2021 May; 22(5):246-255. PubMed ID: 33822477
    [TBL] [Abstract][Full Text] [Related]  

  • 39. More Positive or More Negative? Metagenomic Analysis Reveals Roles of Virome in Human Disease-Related Gut Microbiome.
    Li M; Wang C; Guo Q; Xu C; Xie Z; Tan J; Wu S; Wang P; Guo J; Fang Z; Zhu S; Duan L; Jiang X; Zhu H
    Front Cell Infect Microbiol; 2022; 12():846063. PubMed ID: 35493727
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exploring the mechanism of Xingpi Capsule in diarrhea predominant-irritable bowel syndrome treatment based on multiomics technology.
    Qian W; Li W; Chen X; Cui L; Liu X; Yao J; Wang X; Liu Y; Li C; Wang Y; Wang W
    Phytomedicine; 2023 Mar; 111():154653. PubMed ID: 36641976
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.